A detailed history of State Street Corp transactions in Amgen Inc stock. As of the latest transaction made, State Street Corp holds 29,317,018 shares of AMGN stock, worth $7.74 Billion. This represents 0.39% of its overall portfolio holdings.

Number of Shares
29,317,018
Previous 28,971,481 1.19%
Holding current value
$7.74 Billion
Previous $9.05 Billion 4.35%
% of portfolio
0.39%
Previous 0.4%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $107 Million - $117 Million
345,537 Added 1.19%
29,317,018 $9.45 Billion
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $42.3 Million - $51.4 Million
-160,831 Reduced 0.55%
28,971,481 $9.05 Billion
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $89.2 Million - $108 Million
-331,658 Reduced 1.13%
29,132,312 $8.28 Billion
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $227 Million - $256 Million
888,483 Added 3.11%
29,463,970 $8.49 Billion
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $114 Million - $142 Million
-523,394 Reduced 1.8%
28,575,487 $7.68 Billion
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $14.6 Million - $17.3 Million
-68,251 Reduced 0.23%
29,098,881 $6.46 Billion
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $116 Million - $141 Million
-511,955 Reduced 1.72%
29,167,132 $7.05 Billion
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $139 Million - $176 Million
606,026 Added 2.08%
29,679,087 $7.79 Billion
Q3 2022

Nov 15, 2022

SELL
$224.46 - $253.15 $46.7 Million - $52.6 Million
-207,866 Reduced 0.71%
29,073,061 $6.55 Billion
Q2 2022

Aug 15, 2022

SELL
$230.71 - $256.74 $282 Million - $314 Million
-1,223,493 Reduced 4.01%
29,280,927 $7.12 Billion
Q1 2022

May 16, 2022

BUY
$219.27 - $242.57 $78.4 Million - $86.7 Million
357,413 Added 1.19%
30,504,420 $7.38 Billion
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $100 Million - $115 Million
505,306 Added 1.7%
30,147,007 $6.78 Billion
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $61.5 Million - $72 Million
-289,680 Reduced 0.97%
29,641,701 $6.3 Billion
Q2 2021

Aug 16, 2021

BUY
$233.58 - $259.14 $55.7 Million - $61.8 Million
238,297 Added 0.8%
29,931,381 $7.3 Billion
Q1 2021

May 17, 2021

SELL
$221.91 - $258.6 $88.8 Million - $103 Million
-400,052 Reduced 1.33%
29,693,084 $7.39 Billion
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $257 Million - $306 Million
-1,185,863 Reduced 3.79%
30,093,136 $6.92 Billion
Q3 2020

Nov 10, 2020

BUY
$234.65 - $260.95 $1.18 Billion - $1.31 Billion
5,016,641 Added 19.1%
31,278,999 $7.95 Billion
Q2 2020

Aug 14, 2020

BUY
$197.81 - $242.74 $11 Million - $13.4 Million
55,408 Added 0.21%
26,262,358 $6.19 Billion
Q1 2020

May 11, 2020

BUY
$182.24 - $241.7 $4.78 Billion - $6.33 Billion
26,206,950 New
26,206,950 $5.31 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.